Board comments on fine levied for board composition non-compliance

SEBI penaltyRegulatory & Legal View source PDF Explain this filing

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.9%Reaction day

₹439.00

prior close

₹430.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%-2.8% vs market

Pharmaceuticals peers, median of 157sector+0.0%-2.9% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Microcap 250 and 2.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.3

10m

-2.5

15m

-3.5

30m

-2.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.9-0.1-2.8+0.0-2.9

Next day

+0.2+0.5-0.3-0.1+0.4

-2.0-0.3-1.7-0.9-1.2

-3.2-0.5-2.7-1.3-1.8

-4.0-0.8-3.2-1.6-2.4

-3.6-2.3-1.3-2.3-1.4

-3.6-2.8-0.8-2.9-0.7

15d

-4.4-4.9+0.4-3.1-1.4

-3.8-4.7+0.9-4.4+0.5

+1.2-7.7+8.9-5.7+6.9

+8.7-7.8+16.5-10.7+19.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 157Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Akums Drugs received notices from NSE and BSE for non-compliance with SEBI LODR Regulation 17(1) regarding the Board of Directors composition. The company had earlier submitted a waiver application to NSE. After receiving the final decision from NSE, Akums paid the fine amount on September 18, 2025 within the due timeline. The Board had already commented on the underlying matter earlier.

Likely market impact

Regulatory compliance issue settled; fine amount already paid with no material financial impact disclosed.